🔗 Permalink

Inventor profile of:

Ulf Hedin

City:

Ronninge

Country:

Sweden

Published Applications:

Last publication date:

2024-03-14

Top Assignees for applications by Ulf Hedin

The entities that hold a legal rights for patent applications filed by inventor Hedin Ulf:

Elucid Bioimaging Inc. 7 Boston, MA United States

Recent patent applications by Hedin Ulf

Ulf Hedin from Ronninge, SE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-03-14

US20240087742A1

Physics

SYSTEMS AND METHODS TO AID CLINICAL DECISION SUPPORT FOR COMBINATION THERAPIES FOR CARDIOVASCULAR DISEASE

#2 | 2024-02-22

US20240062901A1

Physics

SYSTEMS AND METHODS TO AID CLINICAL DECISION SUPPORT FOR GLYCEMIC TREATMENT FOR CARDIOVASCULAR DISEASE

#3 | 2024-02-08

US20240046457A1

Physics

Determining likely response to combination therapies for cardiovascular disease non-invasively

#4 | 2024-01-18

US20240021306A1

Physics

SYSTEMS AND METHODS TO AID CLINICAL DECISION SUPPORT FOR ANTI-INFLAMMATORY AND PRO-RESOLVING THERAPIES FOR CARDIOVASCULAR DISEASE

#5 | 2024-01-04

US20240006066A1

Physics

CLINICAL DECISION SUPPORT TO AID INTERVENTIONAL VS MEDICAL THERAPIES FOR CARDIOVASCULAR DISEASE

#6 | 2023-12-28

US20230420144A1

Physics

SCREENING POTENTIAL SUBJECTS FOR ENROLLMENT IN DYSLIPIDEMIA THERAPY CLINICAL TRIALS

#7 | 2023-12-28

US20230420143A1

Physics

SCREENING CANDIDATE DYSLIPIDEMIA AGENTS

#8 | 2023-12-28

US20230420131A1

Physics

CLINICAL DECISION SUPPORT TO AID WATCHFUL WAITING OF CARDIOVASCULAR DISEASE

#9 | 2023-12-28

US20230420130A1

Physics

CLINICAL DECISION SUPPORT TO AID DYSLIPIDEMIA THERAPIES FOR CARDIOVASCULAR DISEASE

#10 | 2023-11-30

US20230386634A1

Physics

Determining likely response to anti-inflammatory and pro-resolving therapies for cardiovascular disease non-invasively

#11 | 2023-11-30

US20230386633A1

Physics

Determining likely response to glycemic treatment for cardiovascular disease non-invasively

#12 | 2023-09-14

US20230290433A1

Physics

VIRTUAL TRANSCRIPTOMICS

#13 | 2023-08-03

US20230245775A1

Physics

IN SILICO SYSTEMS BIOLOGY MODEL OF LIPID-LOWERING THERAPIES FOR CARDIOVASCULAR DISEASE

#14 | 2023-06-29

US20230207137A1

Physics

APPLICATIONS TO OPTIMIZE BENEFIT OF LIPID LOWERING THERAPIES FOR CARDIOVASCULAR DISEASE

#15 | 2023-01-05

US20230005583A1

Physics

Non-invasive determination of likely response to anti-diabetic therapies for cardiovascular disease

#16 | 2023-01-05

US20230005582A1

Physics

Non-invasive determination of likely response to anti-inflammatory therapies for cardiovascular disease

#17 | 2022-12-29

US20220415519A1

Physics

SYSTEMS AND METHODS FOR PATIENT-SPECIFIC THERAPEUTIC RECOMMENDATIONS FOR CARDIOVASCULAR DISEASE

#18 | 2022-12-29

US20220409160A1

Human necessities

Non-invasive determination of likely response to combination therapies for cardiovascular disease

#19 | 2022-12-22

US20220406459A1

Physics

Systems and methods for clinical decision support for lipid-lowering therapies for cardiovascular disease

#20 | 2022-12-22

US20220400963A1

Human necessities

NON-INVASIVE DETERMINATION OF LIKELY RESPONSE TO LIPID LOWERING THERAPIES FOR CARDIOVASCULAR DISEASE

InventorID:

5606212 ⎘